Following its acquisition of Alexander Health Clubs' (
Kelti chairman Chen Wu-kang (陳武剛) confirmed that one of the firm's subsidiaries had invested more than US$7 million to take a controlling stake in Alexander's China-based holding company last month, the Economic Daily reported yesterday.
"[Kelti] now has seven China-based outlets in operation and plans to open new outlets in the future," 67-year-old Chen said, adding that he would head Alexander China and become its new chairman.
Chen also expressed an interest in acquiring Alexander's operations in Taiwan, although he raised concerns over the company's financial position.
"It's not decided yet," he said. "I have urged the government to step in and clarify the complications, which involve the members, its landlords and the rights of debt owners."
Chen said there were five other firms also interested in taking over Alexander's local outlets.
Alexander Group (亞力山大集團) chairwoman Candy Tang (唐雅君), currently on bail, confirmed that Chen's Kelti had taken over the firm's Chinese outlets, the Commercial Times reported yesterday.
She said Kelti has been a successful direct sales firm in China. After the merger, synergies would be created once an integration of the companies' resources and sales channels was completed, she said.
"That was why Chen appeared in court [last Friday as a witness] to clarify [our] NT$250 million cash flow," Tang said.
She said that the firm is in intensive talks with prospective buyers for the Taiwanese outlets.
She said she would welcome a bid from Kelti for Alexander's outlets in Taiwan.
Tang said she was confident the firm would strike a deal to sell Alexander's Taipei headquarters today, which would allow the firm to resume some of its operations.
Tang plans sell the firm's 16 outlets in Taiwan separately. The dancer-turned-entrepreneur said that four Alexander outlets would be jointly taken over by members and the landlord.
Tang also plans to negotiate with potential investors next week in a bid to resume operations at outlets outside of Taipei the report said.
Also see: Alexander closure requires action
Just a few years ago, the millennial generation — generally defined as those born from the early 1980s through the mid-1990s — was synonymous with youthful rebellion. However, now, as the millennials ease into early middle age, they are finding their path out of their parents’ basement to be a lot harder than it was for earlier generations. The fundamental problem is that millennials are not building wealth. The wealth of the median US household headed by someone 35 or younger has actually shrunk in inflation-adjusted terms since the mid-2000s, even as the wealth of older Americans has continued to grow. An
‘LITTLE CHOICE’: The airline said it expected only about 8,000 of its 29,000 employees to be working by next month, but hoped to have 21,000 in the next two years Qantas Airways Ltd plans to cut at least 6,000 jobs and keep 15,000 more workers on extended furloughs as Australia’s largest airline tries to survive the coronavirus pandemic. Qantas yesterday announced a plan to reduce costs by billions of dollars and raise fresh capital. The plan includes grounding 100 planes for a year or more and immediately retiring its six remaining Boeing Co 747 planes. Chief executive Alan Joyce said the airline has to become smaller as it braces for several years of much lower revenues. He said the furloughed workers faced a long interruption to their airline careers. “The actions that we’re taking
Apple Inc’s decision to stop using Intel Corp processors in its Mac computers and switching to its own chips might benefit Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) and boost Taiwan’s high-tech exports, Australia and New Zealand Banking Group (ANZ) said in a note on Tuesday. The US tech giant announced the “Apple silicon” initiative at its annual Worldwide Developers’ Conference, which started on Monday. The company said the first Mac powered by its own chips would debut by the end of this year and all product lines might shift to the new architecture in the next two years. TSMC is likely to
EXPERIMENTAL DRUG: While news about a COVID-19 vaccine is more eye-catching, developing a treatment would be more viable, the Senhwa boss said Senhwa Biosciences Inc (生華科) aims to raise NT$1.5 billion (US$50.57 million) by issuing 15 million new common shares in the third quarter of this year to fund the research of new drugs, including the experimental drug Silmitasertib for the treatment of COVID-19, the company said on Monday. That would be the firm’s largest fundraising effort after it raised more than NT$1.4 billion from an initial public offering on the Taipei Exchange (TPEX) in April 2017, chief financial officer Sarah Chang (張小萍) told the Taipei Times by telephone. The price of the new shares would depend on the firm’s average share price